Browsing Tag
Arbutus Biopharma
2 posts
Roivant Sciences targets new uveitis market as brepocitinib delivers major clinical breakthrough
Roivant Sciences stock rises after brepocitinib's double Phase 3 uveitis success. Explore its FDA plans, cash strength and growth potential.
Moderna faces fresh mRNA patent assault from CureVac as BioNTech tightens legal grip on COVID-19 vaccine royalties
Moderna just settled $950 million in mRNA litigation. Now BioNTech-owned CureVac wants Spikevax royalties too. The patent war is widening.